scholarly journals Artificial Intelligence in Oncology Drug Discovery and Development

2020 ◽  
Keyword(s):  
Artificial Intelligence ◽  
Drug Discovery ◽  
Drug Discovery And Development ◽  
Oncology Drug

scholarly journals Spread and Dynamics of COVID-19 in the Kingdom of Saudi Arabia and Four Other Countries in the Early Phase: A Study for the Development of the Advanced Health System

2021 ◽  
Author(s):  
Shahanavaj Khan ◽  
Asimul Islam ◽  
Ahmad Firoz ◽  
Anis Ahmad Chaudhary ◽  
Mohammad Amjad Kamal ◽  
...  
Keyword(s):  
Artificial Intelligence ◽  
Saudi Arabia ◽  
Health Policy ◽  
Drug Discovery ◽  
Early Phase ◽  
Kingdom Of Saudi Arabia ◽  
Drug Discovery And Development ◽  
First Case ◽  
Daily Report ◽  
The World

Abstract BackgroundThe epidemic of 2019 novel coronavirus (SARS-CoV-2) is challenge to the world which was at first confirmed in the Wuhan city of China in December 2019. It was declared a pandemic by the World Health Organization (WHO) in March 2020. In the current work we evaluated effect of health policy of Saudi Arabia for the management of COVID-19 pandemic in early phase and compared to other four countries. MethodBased on the Ministry of Health, Kingdom of Saudi Arabia (KSA) data, the summary of daily report of COVID-19 was prepared from 02 March to 30 April 2020. Further, the daily report of enhancement in cases and recovery of the patients was also summarized. Moreover, the incidence, death and recoveries of COVID-19 cases in KSA were compared with major infected country including China, Italy, Spain and United State of America (USA). The important role of artificial intelligence was shown for the development of drug targets against to infectious diseases Results In KSA, the first case of COVID-19 was reported on 02 March 2020. Since then, it has affected 22,753 persons till the end of the April 2020. Also, the results showed that the infection rate of COVID-19 increased continuously during the current period of study in KSA. Nevertheless, the rate of death due to COVID-19 is much less with comparison to China, Italy, Spain, and USA due to good medical facilities along with quick action by the government of KSA after the emergence of first case. There is a dire need to develop new platforms and approaches to combat new and old diseases including COVID-19 at warp speed when compared to traditional approaches. DeepDrug’s approach to drug discovery and development showed brighter future towards the discovery of novel drugs against infectious diseases including COVID-19.ConclusionCurrently, there is higher probability of COVID-19 spread at any place. Therefore good health policy, precautionary measures and medical facility of whole nations should be excellent to combat against the COVID-19 pandemic until the reliable vaccine or antiviral drug developed for the proper treatment of virus. The artificial intelligence (AI) based available process might be very helpful for the drug discovery and development against of old and newly discovered diseases including COVID-19.

scholarly journals Translational precision medicine: an industry perspective

2021 ◽  
Vol 19 (1) ◽  
Author(s):  
Dominik Hartl ◽  
Valeria de Luca ◽  
Anna Kostikova ◽  
Jason Laramie ◽  
Scott Kennedy ◽  
...  
Keyword(s):  
Artificial Intelligence ◽  
Drug Discovery ◽  
Precision Medicine ◽  
Paradigm Shift ◽  
Development Process ◽  
New Technologies ◽  
Traditional Approach ◽  
Drug Discovery And Development ◽  
Development Face ◽  
Digital Biomarkers

AbstractIn the era of precision medicine, digital technologies and artificial intelligence, drug discovery and development face unprecedented opportunities for product and business model innovation, fundamentally changing the traditional approach of how drugs are discovered, developed and marketed. Critical to this transformation is the adoption of new technologies in the drug development process, catalyzing the transition from serendipity-driven to data-driven medicine. This paradigm shift comes with a need for both translation and precision, leading to a modern Translational Precision Medicine approach to drug discovery and development. Key components of Translational Precision Medicine are multi-omics profiling, digital biomarkers, model-based data integration, artificial intelligence, biomarker-guided trial designs and patient-centric companion diagnostics. In this review, we summarize and critically discuss the potential and challenges of Translational Precision Medicine from a cross-industry perspective.

scholarly journals Artificial intelligence in drug discovery and development

2020 ◽  
Author(s):  
Debleena Paul ◽  
Gaurav Sanap ◽  
Snehal Shenoy ◽  
Dnyaneshwar Kalyane ◽  
Kiran Kalia ◽  
...  
Keyword(s):  
Artificial Intelligence ◽  
Drug Discovery ◽  
Drug Discovery And Development
Sign in / Sign up

Export Citation Format

Share Document